Endogenous hydrogen peroxide in paraventricular nucleus mediates sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats

Experimental Physiology

Volumn 96, Issue 12, 2011, Pages 1282-1292

  Xu, Yao ^a   Gao, Qing ^a   Gan, Xian Bing ^a   Chen, Lei ^a   Zhang, Lei ^a   Zhu, Guo Qing ^a   Gao, Xing Ya ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRIAZOLE; ANGIOTENSIN II; BRADYKININ; CATALASE; CHLORALOSE; HYDROGEN PEROXIDE; MACROGOL; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; EPICARDIUM; GENERAL ANESTHESIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; KIDNEY; MEAN ARTERIAL PRESSURE; MICROINJECTION; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; RAT; RENOVASCULAR HYPERTENSION; SYMPATHETIC NERVE; SYMPATHETIC REFLEX; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VAGOTOMY;

EID: 82155166341     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.059733     Document Type: Article

References (39)

1. Ardanaz N & Pagano PJ (2006). Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med 231, 237-251.
2. Badoer E (2001). Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 28, 95-99.
3. Biaggioni I (2008). Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? Hypertension 51, 168-171.
4. 1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol 96, 94-103.
5. Darr D & Fridovich I (1986). Irreversible inactivation of catalase by 3-amino-1, 2, 4-triazole. Biochem Pharmacol 35, 36-42.
6. Del Colle S, Morello F, Rabbia F, Milan A, Naso D, Puglisi E, Mulatero P & Veglio F (2007). Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 50, 487-496.
7. Du YH & Chen AF (2007). A 'love triangle' elicited by electrochemistry: complex interactions among cardiac sympathetic afferent, chemo-, and baroreflexes. J Appl Physiol 102, 9-10.
8. Fisher JP & Fadel PJ (2010). Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol 95, 572-580.
9. Fujita M, Ando K, Nagae A & Fujita T (2007). Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 50, 360-367.
10. Grassi G, Seravalle G & Quarti-Trevano F (2010). The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581-586.
11. Grisk O (2005). Sympatho-renal interactions in the determination of arterial pressure: role in hypertension. Exp Physiol 90, 183-187.
12. Guo ZL & Moazzami AR (2004). Involvement of nuclei in the hypothalamus in cardiac sympathoexcitatory reflexes in cats. Brain Res 1006, 36-48.
13. Han Y, Fan ZD, Yuan N, Xie GQ, Gao J, De W, Gao XY & Zhu GQ (2011). Superoxide anions in paraventricular nucleus mediate the enhanced cardiac sympathetic afferent reflex and sympathetic activity in renovascular hypertensive rats. J Appl Physiol 110, 646-652.
14. Han Y, Zhang Y, Wang HJ, Gao XY, Wang W & Zhu GQ (2005). Reactive oxygen species in paraventricular nucleus modulates cardiac sympathetic afferent reflex in rats. Brain Res 1058, 82-90.
15. Hogarth AJ, Mackintosh AF & Mary DASG (2007). The effect of gender on the sympathetic nerve hyperactivity of essential hypertension. J Hum Hypertens 21, 239-245.
16. Katholi RE, Whitlow PL, Winternitz SR & Oparil S (1982). Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension 4, 166-174.
17. B receptors in paraventricular nucleus in control of sympathetic vasomotor tone in hypertension. J Pharmacol Exp Ther 320, 615-626.
18. Li YF, Roy SK, Channon KM, Zucker IH & Patel KP (2002). Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats. Am J Physiol Heart Circ Physiol 282, H594-H601.
19. Li YF, Wang W, Mayhan WG & Patel KP (2006). Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Regul Integr Comp Physiol 290, R1035-R1043.
20. Liu TH, Beckman JS, Freeman BA, Hogan EL & Hsu CY (1989). Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol Heart Circ Physiol 256, H589-H593.
21. Malliani A & Montano N (2002). Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39, 63-68.
22. Mancia G, Grassi G, Giannattasio C & Seravalle G (1999). Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34, 724-728.
23. Morise T, Horita M, Kitagawa I, Shinzato R, Hoshiba Y, Masuya H, Suzuki M & Takekoshi N (2000). The potent role of increased sympathetic tone in pathogenesis of essential hypertension with neurovascular compression. J Hum Hypertens 14, 807-811.
24. Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA & Blankestijn PJ (2007). Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 49, 506-510.
25. Prys-Roberts C (1980). Pathophysiology of hypertension and ischemic heart disease. Int Anesthesiol Clin 18, 1-23.
26. Rahn KH, Barenbrock M & Hausberg M (1999). The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens Suppl 17, S11-S14.
27. Rossi NF, Maliszewska-Scislo M, Chen H, Black SM, Sharma S, Ravikov R & Augustyniak RA (2010). Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats. Exp Physiol 95, 845-857.
28. Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, Wang W & Zhu GQ (2009). Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Arch 458, 247-257.
29. Stocker SD, Meador R & Adams JM (2007). Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension 49, 640-646.
30. Vecchione C, Argenziano L, Fratta L, Pompeo F & Trimarco B (2000). Sympathetic nervous system and hypertension in diabetic patients. Diabetes Nutr Metab 13, 327-331.
31. Xu B, Chen WW, Fan ZD, Han Y, Xiong XQ, Gao XY & Zhu GQ (2011). Responses of neurons in paraventricular nucleus to activation of cardiac afferents and acute myocardial ischemia in rats. Exp Physiol 96, 295-304.
32. 1-adrenoceptor blockade in the rat. Am J Physiol Heart Circ Physiol 295, H2447-H2454.
33. Yu Y, Zhong MK, Li J, Sun XL, Xie GQ, Wang W & Zhu GQ (2007). Endogenous hydrogen peroxide in paraventricular nucleus mediating cardiac sympathetic afferent reflex and regulating sympathetic activity. Pflugers Arch 454, 551-557.
34. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32, 488-495.
35. Zhang Y, Yu Y, Zhang F, Zhong MK, Shi Z, Gao XY, Wang W & Zhu GQ (2006). NAD(P)H oxidase in paraventricular nucleus contributes to the effect of angiotensin II on cardiac sympathetic afferent reflex. Brain Res 1082, 132-141.
36. Zhong MK, Duan YC, Chen AD, Xu B, Gao XY, De W & Zhu GQ (2008a). Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol 93, 746-753.
37. B receptors in paraventricular nucleus in rats. Eur J Neurosci 27, 3226-3232.
38. Zhou LM, Shi Z, Gao J, Han Y, Yuan N, Gao XY & Zhu GQ (2010). Angiotensin-(1-7) and angiotension II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats. Pflugers Arch 459, 681-688.
39. Zhu GQ, Xu Y, Zhou LM, Li YH, Fan LM, Wang W, Gao XY & Chen Q (2009). Enhanced cardiac sympathetic afferent reflex involved in sympathetic overactivity in renovascular hypertensive rats. Exp Physiol 94, 785-794.